Ciaran Smythe
General Practice · Aventura, FLNPI 1093274318
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $21,129 of the $23,697 with a category attached, or 89.2%. It is spread thinly across 36 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 375 payments — averaging $63.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sanofi$2K
- Janssen Scientific Affairs, LLC$2K
- Lilly USA, LLC$1K
- Almirall LLC$1K
- Arcutis Biotherapeutics, Inc.$1K
- plus $12K from 30 others
Across 6 payments — averaging $109.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$658
What the payments were for
- Consulting fees$1,1035%
- Travel & lodging$1,0294%
- Food & beverage$21,12989%
- Education$4362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $3,363 |
| Sanofi | 42 | $2,366 |
| Janssen Scientific Affairs, LLC | 11 | $2,258 |
| Lilly USA, LLC | 24 | $1,399 |
| Almirall LLC | 24 | $1,268 |
| Arcutis Biotherapeutics, Inc. | 24 | $1,199 |
| Novartis | 18 | $1,160 |
| Incyte Corporation | 22 | $1,132 |
| UCB, Inc. | 16 | $1,114 |
| Sun Pharmaceutical Industries Inc. | 18 | $1,073 |
| Johnson & Johnson | 23 | $1,034 |
| Galderma Laboratories, L.p. | 12 | $1,000 |
| Pfizer | 21 | $972 |
| E.r. Squibb & Sons, L.L.C. | 7 | $602 |
| Regeneron Healthcare Solutions, Inc. | 11 | $550 |
| Biofrontera Inc. | 11 | $464 |
| Boehringer Ingelheim | 5 | $401 |
| Kyowa Kirin, Inc. | 6 | $325 |
| Kerecis Limited | 2 | $325 |
| Amgen | 3 | $252 |
| LEO Pharma Inc. | 3 | $217 |
| Blueprint Medicines Corporation | 2 | $210 |
| Journey Medical Corporation | 3 | $204 |
| Merz North America, Inc. | 1 | $194 |
| Sandoz | 3 | $125 |
| Dermavant Sciences, Inc. | 3 | $122 |
| Organon | 1 | $107 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| EPI Health, LLC | 1 | $42 |
| Medtronic | 1 | $33 |
| Biowound Solutions, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Mimedx Group, Inc. | 1 | $17 |
| KCI USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,697 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Other general practice in Aventura
- Arun GargAventura$42K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.